Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nutr ; 31(3): 396-404, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22122868

ABSTRACT

BACKGROUND & AIMS: Omega-3 fatty acids (ω-3FA) attenuate postoperative immunosuppression vis-à-vis infection. Since immune-surveillance targets metastasizing cancer cells, we assessed the effect of ω-3FA consumption on 1) early post-operative Natural Killer cell (NK) cytotoxicity and metastases and 2) long-term recurrence-free survival, in two rodent models of surgery-promoted metastases. METHODS: C57BL/6J mice were fed standard, ω-3FA-enriched, or ω-6FA-enriched chow, beginning one week before subcutaneous footpad implantation of syngeneic melanoma cells. When tumors reached the volume of 110 µl, the tumor-bearing footpad was amputated, and long-term recurrence-free survival was assessed. Also, F344 rats were fed ω-3FA or ω-6FA for a month before undergoing or not undergoing laparotomy, and were intravenously inoculated with radio-labeled syngeneic adenocarcinoma cells. Marginating-pulmonary (MP)-leukocytes were harvested, and lung tumor retention (LTR) of metastases was assessed. RESULTS: ω-3FA consumption did not affect the growth of footpad tumors, but significantly enhanced post-amputation recurrence-free survival in mice. Surgery had a deleterious effect on NK cell activity and LTR whereas ω-3FA had large beneficial effects in non-operated rats and an even greater impact in operated rats. CONCLUSIONS: ω-3FA feeding attenuates or even overcomes postoperative NK cell suppression, increases resistance to experimental and spontaneous metastasis, and enhances recurrence-free survival following excision of metastasizing primary tumors. These findings warrant clinical studies of ω-3FA-based nutrition in patients undergoing resection of a primary tumor.


Subject(s)
Fatty Acids, Omega-3/therapeutic use , Fish Oils/therapeutic use , Immunologic Surveillance , Neoplasm Seeding , Neoplasms, Experimental/immunology , Neoplasms, Experimental/prevention & control , Adenocarcinoma/diet therapy , Adenocarcinoma/immunology , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Animals , Combined Modality Therapy , Cytotoxicity, Immunologic , Female , Killer Cells, Natural/immunology , Leukocytes/immunology , Lung Neoplasms/immunology , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Male , Melanoma, Experimental/immunology , Melanoma, Experimental/prevention & control , Melanoma, Experimental/secondary , Melanoma, Experimental/surgery , Mice , Mice, Inbred C57BL , Neoplasms, Experimental/diet therapy , Neoplasms, Experimental/surgery , Random Allocation , Rats , Rats, Inbred F344 , Secondary Prevention , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...